Defining Gaps in the Management of Familial Hypercholesterolaemia Using Electronic Health Records in Rural General Practice

Kyle Selga; Maverick Daniel; Samuel Moffatt; Louis Steyn; Benjamin Whittaker; Jennene Greenhill; Ian Hamilton-Craig

doi:10.1016/j.hlc.2025.03.004

Defining Gaps in the Management of Familial Hypercholesterolaemia Using Electronic Health Records in Rural General Practice

Kyle Selga, Maverick Daniel, Samuel Moffatt, Louis Steyn, Benjamin Whittaker, Jennene Greenhill, Ian Hamilton-Craig

College of Medicine and Public Health

Research output: Contribution to journal › Article › peer-review

3 Downloads (Pure)

Abstract

Familial hypercholesterolaemia (FH) affects around 1:250 of the general population and, if untreated, results in premature cardiovascular disease (CVD) due to elevated levels of low-density lipoprotein cholesterol (LDL-C) [1].
Only 10% of FH patients are diagnosed, with the majority undertreated, resulting in poor achievement of target LDL-C levels [1]. Most Australian general practices have around 50–100 FH patients, the majority of whom can be detected using electronic health records (EHR) [2,3]. In a previous study of rural patients with severe hypercholesterolaemia, we found 2% of 17,612 patients had cholesterol levels >7.5 mmol/L and were likely to have FH [4].

Original language	English
Pages (from-to)	730-732
Number of pages	3
Journal	Heart Lung and Circulation
Volume	34
Issue number	7
DOIs	https://doi.org/10.1016/j.hlc.2025.03.004
Publication status	Published - Jul 2025

Keywords

Electronic health records
Familial hypercholesterolaemia
Rural general practice
Suboptimal lipid lowering therapy

Access to Document

10.1016/j.hlc.2025.03.004Licence: CC BY

Published versionFinal published version, 159 KBLicence: CC BY

Cite this

@article{6684c328350b47839fcc17cb419609c6,

title = "Defining Gaps in the Management of Familial Hypercholesterolaemia Using Electronic Health Records in Rural General Practice",

abstract = "Familial hypercholesterolaemia (FH) affects around 1:250 of the general population and, if untreated, results in premature cardiovascular disease (CVD) due to elevated levels of low-density lipoprotein cholesterol (LDL-C) [1].Only 10% of FH patients are diagnosed, with the majority undertreated, resulting in poor achievement of target LDL-C levels [1]. Most Australian general practices have around 50–100 FH patients, the majority of whom can be detected using electronic health records (EHR) [2,3]. In a previous study of rural patients with severe hypercholesterolaemia, we found 2% of 17,612 patients had cholesterol levels >7.5 mmol/L and were likely to have FH [4].",

keywords = "Electronic health records, Familial hypercholesterolaemia, Rural general practice, Suboptimal lipid lowering therapy",

author = "Kyle Selga and Maverick Daniel and Samuel Moffatt and Louis Steyn and Benjamin Whittaker and Jennene Greenhill and Ian Hamilton-Craig",

year = "2025",

month = jul,

doi = "10.1016/j.hlc.2025.03.004",

language = "English",

volume = "34",

pages = "730--732",

journal = "Heart Lung and Circulation",

issn = "1443-9506",

publisher = "Elsevier Australia",

number = "7",

}

TY - JOUR

T1 - Defining Gaps in the Management of Familial Hypercholesterolaemia Using Electronic Health Records in Rural General Practice

AU - Selga, Kyle

AU - Daniel, Maverick

AU - Moffatt, Samuel

AU - Steyn, Louis

AU - Whittaker, Benjamin

AU - Greenhill, Jennene

AU - Hamilton-Craig, Ian

PY - 2025/7

Y1 - 2025/7

N2 - Familial hypercholesterolaemia (FH) affects around 1:250 of the general population and, if untreated, results in premature cardiovascular disease (CVD) due to elevated levels of low-density lipoprotein cholesterol (LDL-C) [1].Only 10% of FH patients are diagnosed, with the majority undertreated, resulting in poor achievement of target LDL-C levels [1]. Most Australian general practices have around 50–100 FH patients, the majority of whom can be detected using electronic health records (EHR) [2,3]. In a previous study of rural patients with severe hypercholesterolaemia, we found 2% of 17,612 patients had cholesterol levels >7.5 mmol/L and were likely to have FH [4].

AB - Familial hypercholesterolaemia (FH) affects around 1:250 of the general population and, if untreated, results in premature cardiovascular disease (CVD) due to elevated levels of low-density lipoprotein cholesterol (LDL-C) [1].Only 10% of FH patients are diagnosed, with the majority undertreated, resulting in poor achievement of target LDL-C levels [1]. Most Australian general practices have around 50–100 FH patients, the majority of whom can be detected using electronic health records (EHR) [2,3]. In a previous study of rural patients with severe hypercholesterolaemia, we found 2% of 17,612 patients had cholesterol levels >7.5 mmol/L and were likely to have FH [4].

KW - Electronic health records

KW - Familial hypercholesterolaemia

KW - Rural general practice

KW - Suboptimal lipid lowering therapy

UR - http://www.scopus.com/inward/record.url?scp=105003956149&partnerID=8YFLogxK

U2 - 10.1016/j.hlc.2025.03.004

DO - 10.1016/j.hlc.2025.03.004

M3 - Article

C2 - 40312178

AN - SCOPUS:105003956149

SN - 1443-9506

VL - 34

SP - 730

EP - 732

JO - Heart Lung and Circulation

JF - Heart Lung and Circulation

IS - 7

ER -

Defining Gaps in the Management of Familial Hypercholesterolaemia Using Electronic Health Records in Rural General Practice

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this